Second Quarter Highlights

The company:

· Continued to leverage its well-leased development pipeline, comprising approximately 2.3 million rentable square feet, by delivering two Class A life science buildings during the quarter: 430 Cambridge Science Park in Cambridge, United Kingdom, which is 100% leased to Takeda, and 450 Kendall Street in Cambridge, Massachusetts. The 450 Kendall Street property, in the heart of Kendall Square, is approximately 66% leased as of today, including Eli Lilly and MPM Capital, with ongoing discussions and negotiations for the remainder of the space;

· Added two new projects totaling approximately 439,500 rentable square feet to its development pipeline with the start of construction on a 155,000 square foot build-to-suit for Illumina at Granta Park in Cambridge, United Kingdom and approximately 284,500 square feet at the Chesterfield Building in Durham, North Carolina, which is anchored by a 100,000 square foot lease to Duke University.

· Expanded its presence and value creation opportunity in the growing and supply-constrained University Towne Centre submarket of San Diego with the acquisition of Towne Centre Technology Park, comprising approximately 182,900 square feet of laboratory and office space and additional development potential of 104,500 square feet, for approximately $84.0 million;

· Generated net gains totaling approximately $50.5 million, primarily from the sale of an equity investment in a single life science company; and

· Earned an upgrade to its investment grade corporate credit rating from Moody's Investors Service to Baa2 from Baa3.

Alan Gold, Chairman, President and Chief Executive Officer of BioMed Realty, commented, “The health and strength of the life science industry continues to drive robust growth and demand for high quality real estate. This growth and demand that we are seeing further validates our strategy of staying focused on the entire continuum of the life science real estate sector.”

Second Quarter 2015 Portfolio Update

During the quarter ended June 30, 2015, the company executed 46 leasing transactions representing a record 1.3 million square feet of gross leasing, driving positive net absorption for the quarter of 218,400 square feet within the operating portfolio, and an additional 370,300 square feet of absorption across the company's development portfolio. As of June 30, 2015, the operating portfolio leased percentage based on square footage improved 180 basis points from 89.2% to 91.0%. The active new construction portfolio now comprises eight projects totaling over 2.3 million square feet. At quarter end, five of the eight projects are 100% pre-leased with a weighted-average lease term in excess of 15 years, and the entire portfolio is 75.0% pre-leased.

Also during the second quarter, the company acquired the Towne Centre Technology Park for $84.0 million to meet the strong and growing demand in the expanding core life science submarket of University Towne Centre in San Diego. The three-building property, comprised of approximately 182,900 square feet, is part of the active redevelopment pipeline and includes additional potential development of 104,500 square feet in the company's land bank.

In the quarter, the company recorded an impairment loss of $35.1 million, primarily as a result of the sale of its King of Prussia property in Radnor, PA for approximately $35.2 million in gross proceeds.

Subsequent to the end of the second quarter, the company completed the acquisition of a historical rehabilitation development project in Providence, Rhode Island which is expected to comprise approximately 267,000 square feet and is 100% leased to Brown University, the University of Rhode Island and Rhode Island College for expected use as office space and a nursing school. The project also includes development of 172 residential units primarily for use by Brown University graduate school students and a 750-space parking garage.

BioMed also recently executed three new leases at the Pacific Research Center aggregating approximately 102,800 square feet, including new leases with Stanford Health Care and Carbylan Therapeutics. As a result of these three leases, the Pacific Research Center is now approximately 88% leased.

Second Quarter 2015 Financial Results

Total revenues for the second quarter were approximately $158.0 million, compared to approximately $171.2 million for the same period in 2014. Rental revenues for the second quarter were approximately $116.3 million, compared to $120.9 million for the same period in 2014.

CFFO and FFO, calculated in accordance with standards established by NAREIT, for the second quarter were $0.58 per diluted share. This amount includes realized gains totaling $50.5 million, or $0.24 per diluted share, net of an allocation of income attributable to noncontrolling interests, primarily from the sale of equity investments in a single life science company. CFFO and FFO for the same period in 2014 were $0.40 per diluted share.

The company reported net income attributable to common stockholders for the quarter of approximately $23.6 million, or $0.11 per diluted share, compared to $18.6 million, or $0.10 per diluted share, for the same period in 2014.

BioMed Realty planned to conduct a conference call and webcast on Wednesday to discuss t financial results and operations for the quarter.